Viewing StudyNCT00454779



Ignite Creation Date: 2024-05-05 @ 5:26 PM
Last Modification Date: 2024-10-26 @ 9:31 AM
Study NCT ID: NCT00454779
Status: COMPLETED
Last Update Posted: 2018-10-17
First Post: 2007-03-29

Brief Title: PARTNER Panitumumab Added to Regimen for Treatment of Head aNd Neck Cancer Evaluation of Response
Sponsor: Amgen
Organization: Amgen

Conditions & Keywords Data

Conditions:
Name
Metastatic or Recurrent Squamous Cell Carcinoma of Head and Neck
Keywords:
Name View
Recurrent View
SCCHNC View
Metastatic View